Repeat cardiovascular risk assessment after four years: Is there improvement in risk prediction?

PLoS ONE

Volumn 11, Issue 2, 2016, Pages

  Chamnan, Parinya ^a,b   Simmons, Rebecca K ^a   Sharp, Stephen J ^a   Khaw, Kay Tee ^c   Wareham, Nicholas J ^a   Griffin, Simon J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b Sanpasitthiprasong Hospital   (Thailand)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MEDICAL INFORMATION; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK RECLASSIFICATION; CARDIOVASCULAR DISEASES; HEALTH SURVEY; INCIDENCE; MIDDLE AGED; RISK FACTOR;

ADULT; AGED; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PUBLIC HEALTH SURVEILLANCE; RISK ASSESSMENT; RISK FACTORS; ROC CURVE;

EID: 84960977651     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0147417     Document Type: Article

References (25)

1. Lloyd-Jones DM (2010) Cardiovascular risk prediction: basic concepts, current status, and future directions. Circulation 121: 1768-1777. doi: 10.1161/CIRCULATIONAHA.109.849166 PMID: 20404268
2. Hingorani AD, Psaty BM (2009) Primary prevention of cardiovascular disease: time to get more or less personal? JAMA 302: 2144-2145. doi: 10.1001/jama.2009.1698 PMID: 19920239
3. National Institute for Health and Clinical Excellence (2008) Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. London: National Institute for Health and Clinical Excellence.
4. Prepared b (2005) JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 91 Suppl 5: v1-52. PMID: 16365341
5. Prepared b (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106: 3143-3421. PMID: 12485966
6. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al. (2007) European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J 28: 2375-2414. PMID: 17726041
7. D'Agostino RB Sr., Grundy S, Sullivan LM, Wilson P (2001) Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 286: 180-187. PMID: 11448281
8. Brindle P, Beswick A, Fahey T, Ebrahim S (2006) Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review. Heart 92: 1752-1759. PMID: 16621883
9. Lloyd-Jones DM, Wilson PW, Larson MG, Beiser A, Leip EP, D'Agostino RB, et al. (2004) Framingham risk score and prediction of lifetime risk for coronary heart disease. Am J Cardiol 94: 20-24. PMID: 15219502
10. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, et al. (2010) 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 122: e584-636. doi: 10.1161/CIR.0b013e3182051b4c PMID: 21098428
11. Chamnan P, Simmons RK, Sharp SJ, Griffin SJ, Wareham NJ (2009) Cardiovascular risk assessment scores for people with diabetes: asystematic review. Diabetologia 52: 2001-2014. doi: 10.1007/s00125-009-1454-0 PMID: 19629430
12. Cupples LA, D'Agostino RB, Anderson K, Kannel WB (1988) Comparison of baseline and repeated measure covariate techniques in the Framingham Heart Study. Stat Med 7: 205-222. PMID: 3353604
13. Karp I, Abrahamowicz M, Bartlett G, Pilote L (2004) Updated riskfactor values and the ability of the multivariable risk score to predict coronary heart disease. Am J Epidemiol 160: 707-716. PMID: 15383415
14. Gaziano JM, Wilson PW (2012) Cardiovascular risk assessment in the 21st century. Jama 308: 816-817. doi: 10.1001/2012.jama.10456 PMID: 22910761
15. Day N, Oakes S, Luben R, Khaw KT, Bingham S, Welch A, et al. (1999) EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer 80 Suppl 1: 95-103.
16. Chamnan P, Simmons RK, Forouhi NG, Luben RN, Khaw KT, Wareham NJ, et al. (2011) Incidence of type 2 diabetes using proposed HbA1c diagnostic criteria in the european prospective investigation of cancer-norfolkcohort: implications for preventive strategies. Diabetes Care 34: 950-956. doi: 10.2337/dc09-2326 PMID: 20622160
17. D'Agostino RB Sr., Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. (2008) General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117: 743-753. doi: 10.1161/CIRCULATIONAHA.107.699579 PMID: 18212285
18. Boekholdt SM, Peters RJ, Day NE, Luben R, Bingham SA, Wareham NJ, et al. (2004) Macrophage migration inhibitory factor and the risk of myocardial infarction or death due to coronary artery disease in adults without prior myocardial infarction or stroke: the EPIC-Norfolk Prospective Population study. Am J Med 117:390-397.
19. Department of Health (2008) Putting prevention first: Vascular checks risk assessment and management - impact assessment.
20. Department of Health (2008) Economic modelling for vascular checks.
21. Lloyd-Jones DM (2006) Short-term versus long-term risk for coronary artery disease: implications for lipid guidelines. Curr Opin Lipidol 17: 619-625. PMID: 17095905
22. Marma AK, Berry JD, Ning H, Persell SD, Lloyd-Jones DM (2010) Distribution of 10-year and lifetime predicted risks for cardiovascular disease in US adults: findings from the National Health and Nutrition Examination Survey 2003 to 2006. Circ Cardiovasc Qual Outcomes 3: 8-14. doi: 10.1161/CIRCOUTCOMES.109.869727 PMID: 20123666
23. Hippisley-Cox J, Coupland C, Robson J, Brindle P (2011) Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database. BMJ 341: c6624.
24. Persell SD, Zei C, Cameron KA, Zielinski M, Lloyd-Jones DM (2010) Potential use of 10-year and lifetime coronary risk information for preventive cardiology prescribing decisions: a primary care physician survey. Arch Intern Med 170: 470-477. doi: 10.1001/archinternmed.2009.525 PMID: 20212185
25. Jackson R, Kerr A, Wells S (2011) Is estimating lifetime cardiovascular risk useful? BMJ 341: c7379.